Vestmark Advisory Solutions’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67M Sell
45,540
-17,693
-28% -$742K 0.03% 583
2026
Q1
$2.04M Sell
63,233
-11,027
-15% -$408K 0.02% 617
2025
Q4
$3.13M Sell
74,260
-14,988
-17% -$604K 0.04% 435
2025
Q3
$3.06M Sell
89,248
-87,964
-50% -$2.52M 0.06% 327
2025
Q2
$4.79M Buy
177,212
+81,007
+84% +$2.35M 0.07% 211
2025
Q1
$2.85M Sell
96,205
-41,162
-30% -$1.57M 0.07% 283
2024
Q4
$4.77M Buy
137,367
+14,791
+12% +$560K 0.16% 132
2024
Q3
$4.17M Sell
122,576
-26,169
-18% -$736K 0.16% 137
2024
Q2
$3.22M Sell
148,745
-51,457
-26% -$1.08M 0.13% 165
2024
Q1
$4.44M Buy
200,202
+23,887
+14% +$583K 0.19% 129
2023
Q4
$4.85M Buy
+176,315
New +$4.26M 0.25% 98

Other funds holding VCYT

Vestmark Advisory Solutions's VCYT Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its Veracyte (VCYT) stake by 28% in Q2 2026, selling an estimated $742K and leaving 45,540 shares worth $2.67M. The position accounts for 0.03% of the portfolio, ranked #583.

Vestmark Advisory Solutions first reported a position in VCYT in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.85M in Q4 2023. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Vestmark Advisory Solutions held 45,540 shares of Veracyte worth $2.67M as of Q2 2026.
  • Vestmark Advisory Solutions sold 17,693 Veracyte shares in Q2 2026, an estimated $742K.
  • Veracyte made up 0.03% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #583 holding.
  • Vestmark Advisory Solutions first reported a position in Veracyte in Q4 2023 and has held it in 11 quarters since.
  • Vestmark Advisory Solutions's Veracyte position peaked at $4.85M in Q4 2023.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.